Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (321-330 of 910) with videos related to

Pageof 91
Sort By:
European Heart Journal|October 17, 2006
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarctionRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
Journal of the American College of Cardiology|March 29, 2023
Early Lead Extraction for Infected Implanted Cardiac Electronic Devices: JACC Review Topic of the WeekDhanunjaya R Lakkireddy, Douglas S Segar, Ami Sood, et al.
The American Journal of Medicine|May 30, 2002
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac eventsL Kristin Newby, Robert M Califf, Harvey D White, et al.
American Heart Journal|December 13, 2005
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes, Shamir R Mehta, Salim Yusuf, et al.
Archives of Internal Medicine|March 30, 2011
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trialS Michael Gharacholou, Renato D Lopes, Karen P Alexander, et al.
The American Journal of Cardiology|July 7, 2009
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparinE Marc Jolicoeur, E Magnus Ohman, Emily Honeycutt, et al.
The American Journal of Cardiology|September 3, 2019
Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)Sarah A Goldstein, Jennifer Green, Kurt Huber, et al.
Clinical Trials (London, England)|February 20, 2008
Do we need to adjudicate major clinical events?Christopher B Granger, Victor Vogel, Steve R Cummings, et al.
Journal of Electrocardiology|May 5, 2007
Time to reperfusion in acute myocardial infarction. It is time to reduce it!Alejandro Barbagelata, Eduardo R Perna, Peter Clemmensen, et al.
European Heart Journal|September 10, 2013
Physical activity in patients with stable coronary heart disease: an international perspectiveRalph Stewart, Claes Held, Rebekkah Brown, et al.
Pageof 91

Showing results (321-330 of 910) with videos related to

Sort By:
Pageof 91
European Heart Journal|October 17, 2006
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarctionRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
Journal of the American College of Cardiology|March 29, 2023
Early Lead Extraction for Infected Implanted Cardiac Electronic Devices: JACC Review Topic of the WeekDhanunjaya R Lakkireddy, Douglas S Segar, Ami Sood, et al.
The American Journal of Medicine|May 30, 2002
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac eventsL Kristin Newby, Robert M Califf, Harvey D White, et al.
American Heart Journal|December 13, 2005
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes, Shamir R Mehta, Salim Yusuf, et al.
Archives of Internal Medicine|March 30, 2011
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trialS Michael Gharacholou, Renato D Lopes, Karen P Alexander, et al.
The American Journal of Cardiology|July 7, 2009
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparinE Marc Jolicoeur, E Magnus Ohman, Emily Honeycutt, et al.
The American Journal of Cardiology|September 3, 2019
Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)Sarah A Goldstein, Jennifer Green, Kurt Huber, et al.
Clinical Trials (London, England)|February 20, 2008
Do we need to adjudicate major clinical events?Christopher B Granger, Victor Vogel, Steve R Cummings, et al.
Journal of Electrocardiology|May 5, 2007
Time to reperfusion in acute myocardial infarction. It is time to reduce it!Alejandro Barbagelata, Eduardo R Perna, Peter Clemmensen, et al.
European Heart Journal|September 10, 2013
Physical activity in patients with stable coronary heart disease: an international perspectiveRalph Stewart, Claes Held, Rebekkah Brown, et al.
Pageof 91